In the present study, phagocytosis and the oxidative metabolism of neutrophil granulocytes from five clinically healthy persons with different degrees of myeloperoxidase deficiency were investigated and compared to those of normal persons. The identification of individuals with myeloperoxidase deficiency was performed with the Bayer/Technicon H3 blood cell counter, which differentiates the leukocytes by measuring the peroxidase activity. Neutrophils of three out of five investigated myeloperoxidase deficient persons showed extremly low peroxidase indices (-53 and lower), but only the neutrophils of one person totally lacked myeloperoxidase. This was demonstrated by comparing myeloperoxidase mass concentration measured with an enzyme immunoassay, lack of HOC1 production, and was further confirmed by measuring luminol-and lucigenin-enhanced chemiluminescence. Characteristically, myeloperoxidase deficient granulocytes showed a strikingly decreased luminol-enhanced chemiluminescence while the lucigenin-enhanced chemiluminescence was significantly increased compared to normal granulocytes. Although there is a DNA sequence homology of about 70%, the activity of peroxidase in eosinophils was not affected in any myeloperoxidase deficient person investigated. Moreover, a person with a very rare defect of eosinophil peroxidase had completely normal myeloperoxidase activity. The lack of myeloperoxidase activity is compensated for by an increased phagocytic activity, an increased production of Superoxide anion (lucigeninchemiluminescence) and probably by an alternative metabolism of H 2 O 2 ; since persons lacking myeloperoxidase activity do not normally suffer from severe infections, H 2 O 2 is obviously metabolized to other reactive oxygen substrates than HOC1, e. g. to OH-radicals.
Introduction
Neutrophil granulocytes are the first line of defence against invading microorganisms such as bacteria and fungi (1) . Apart from other defence mechanisms, the generation of reactive oxygen compounds plays an important role in this process. After the activation of an NADPHoxidase 2 ) complex, Superoxide anion is generated, which is disproportionated to oxygen and H 2 O 2 , from which the highly potent HOC1 is generated in the myeloperoxidase reaction. Neutrophil granulocytes, and to a lesser degree monocytes, contain myeloperoxidase-rich azurophil granules. Eosinophil granulocytes contain another peroxidase, the eosinophil peroxidase, which shares about 70% DNA sequence homology with myeloperoxidase (2) . The different pattern of peroxidase content in the white blood cell fraction is the basis for leukocyte differentiation by ! ) This work was supported by a grant from the Fortune-Programm of the University of Tübingen. 2 ) Enzymes: Catalase,EC 1.11.1.6 Eosinophil peroxidase, EC 1.11.1.-Myeloperoxidase, EC 1.11.1.7 NADPH-oxidase, EC 1.6.99. 6 Superoxide dismutase, EC 1.15.1. 1 an automatic blood cell counter, the Bayer/Technicon H3. The introduction of such systems in routine blood cell analysis contributed mainly to the detection of partial or complete myeloperoxidase deficiency, which is a rather frequent event (prevalence of 1 :2000-1 :4000) (3) . Considering the important role of HOC1 for effective killing of microorganisms, it is surprising that most myeloperoxidase deficient persons do not suffer from life threatening infections more frequently than persons with normal myeloperoxidase activity. This fact stands in severe contrast to persons whose granulocytes are deficient in NADPH-oxidase (chronic granulomatous disease) and consequently do not produce any reactive oxygen compounds. Therefore, these cells are not able to kill pathogens that are catalase-positive and/or do not generate endogenous H 2 O 2 (4) . Thus, in myeloperoxidase deficient cells there is obviously an interplay of other mechanism, which compensate for the inability to generate HOC1 from H 2 O 2 .
In the present study, we characterize the phagocytic activity and the oxygen metabolism of granulocytes in 5 clinically healthy persons with different degrees of myeloperoxidase deficiency compared to persons with normal myeloperoxidase content.
Materials and Methods

Probands
Five clinically healthy myeloperoxidase deficient blood donors (4 females, I male) (mean peroxidase index ranged between -30 and -58) were found by routine analysis on the Bayer/Tcchnicon H3. They are unrelated probands and their age ranged from 25-40 years. Proband 6 (a six year old girl, suffering from dystrophia of unclear origin) with a rare eosinophil peroxidase deficiency was found by routine blood measurement on the H3. Normal blood controls of 5 healthy persons, aged between 25-45 years, were selected, based on their myeloperoxidase activity. Founded on measurements of several thousand healthy donors, the mean peroxidase index was arbitrarily set as "zero" by the manufacturer (5, 6) and the values of the mean peroxidase index between -1-10 and -10 were considered as 'normal'. The mean peroxidase index of an individual sample was calculated by the H3 according to the equation:
(MPX)a -(MPX)n (MPX)n X 100 = mean peroxidase index (MPX)a: mean peroxidase activity of the current sample (MPX)n: mean peroxidase activity of a collection of normal donors.
Cell counting and measurement of myeloperoxidase activity
Blood cell analysis was carried out by flow cytometry using the Bayer/Technicon H3. Differentiation of leukocytes was performed by peroxidase staining and by simultaneous measurement of lightscattering ("perox-chanel"). For peroxidase staining, red cells were lysed in the H3-integrated "perox-chamber", and leukocytes were fixed with formalin and stained for peroxidase using H 2 O 2 and 4-chloro-1-naphthol as chromogen (7, 8) . The cell distribution pattern was plotted by a socalled leukogram with peroxidase activity on the x-axis and light-scattering on the y-axis (see fig. 1 ). In parallel, low and wide angle scattering of cell nuclei is also registrated ("basophilic chanel", not shown in fig. 1 ).
Chemicals and media
Histopaque® 1119 and 1077; phorbol 12-myristate 13-acetate; catalase (40000-60000 U/mg); Superoxide dismutase (30000 U/mg); bovine serum albumin; ferricytochrome c; 5,5'-dithio-bis(2-nitrobenzoic acid); Na-dithionite; 5-amino-2.3-dihydro-l,4-phthalazinedione (luminol) and bis-N-methylacridinium nitrate (lucigenin) were purchased from Sigma (M nchen, Germany). Hanks' balanced salt solution (with Ca^/Mg 2 " 1 ", but without phenol red) and phosphate buffered saline were purchased from Biochrom (Berlin, Germany); Zymosan: from ICN (Eschwege, Germany) and H 2 O 2 (300 g/kg) from Merck (Darmstadt, Germany).
Opsonized zymosan was prepared by incubation of 250 mg zymosan with 25 ml of human pool serum for 30 minutes at 37 °C. After washing, opsonized zymosan was suspended in 3.5 ml phosphate buffered saline and frozen until use (9) .
Isolation of polymorphonuclear leukocytes
Polymorphonuclear leukocytes were isolated from heparinized whole blood loaded on a two step density gradient with Histopaque® 1119 and 1077 by centrifugation at 500 g, at 2l°C for 25 minutes. Polymorphonuclear leukocytes were collected, washed twice in Hanks' balanced salt solution with Ca For separating the eosinophil granulocytes from neutrophils, the magnetic cell sorter technique (Miltenyi Biotec, Bergisch Gladbach, Germany) was used (10) . Cells were incubated with an anti-CD16-antibody conjugated with superparamagnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany). Incubating the granulocytes with this antibody leads to a binding of marked neutrophils by passing the cell-suspension through a magnetic column. The unmarked eosinophils are found in the eluate (purity 82%), the neutrophils are retained and washed out with phosphate buffered saline after separating the column from the magnetic field (purity 98%). The resulting cells were used for determination of cross-reactivity of myeloperoxidase and eosinophil peroxidase with the enzyme immunoassay (see below).
Phagocytosis assay
A commercially available test kit from Orpegen (Heidelberg, Germany) was used according to the manufacturer's instructions. The test was intended to investigate the phagocytic activity of polymorphonuclear leukocytes and macrophages by flow cytometry adding fluorescein isothiocyanate-loaded E. coli. Fluorescence activated cell scan analysis permits the determination of the percentage of granulocytes which can phagocytose fluorescein isothiocyanate-labeled E. coli as well as phagocytic activity of every individual cell. Flow cytometry was carried out on a fluorescence activated cell scan from Becton-Dickinson (Heidelberg, Germany). The data were analyzed using the Lysis II program from Becton-Dickinson.
Myeloperoxidase enzyme immunoassay
The myeloperoxidase enzyme immunoassay kit (Biermann, Bad Nauheim, Germany) is an enzyme linked immunosorbent assay for measuring myeloperoxidase mass concentrations in several biological samples. Isolated granulocytes (2 Χ 10 6 cells, or in some experiments, neutrophils and eosinophils, previously separated by magnetic cell sorting) were homogenized in 1 ml Tween 80/phosphate buffered saline (1 ml/1) by 3 cycles of freezing (-70 °C) and thawing (37 °C) and sonicated for 30 seconds. The final suspension was centrifuged at 12 000 g for 15 minutes and the supernatant was collected and analyzed. The immunological cross-reactivity toward the eosinophil peroxidase has been evaluated as lower than 2% (product information of Biermann, Bad Nauheim).
O 2 consumption and H 2 0 2 measurement
The initial rate of oxygen consumption of polymorphonuclear leukocytes (3.75 X 10 6 /1 ml Hanks' balanced salt solution) Was measured under basal and stimulated conditions (addition of 100 μΐ opsonized zymosan (10:1 diluted)) using a Clark electrode (Bachofer, Reutlingen, Germany) at 37 °C for 5-10 minutes (9). The steadystate concentration of H 2 0 2 was measured 5 minutes after the addition of opsonized zymosan to the cell suspension. For this purpose, 10 μΐ of catalase solution [60 units] were added to the incubation chamber and the increase in oxygen was monitored according to the equation
An H 2 O 2 calibration curve was established by adding increasing amounts of H 2 0 2 to 1 ml incubation buffer [containing 60 units catalase] which was previously partially deoxygenated by a stepwise addition of small amounts of sodium dithionite.
Superoxide anion assay
Superoxide anion production was determined as Superoxide dismutase-inhibitable reduction of ferricytpchrome c by a microassay according to Mayo & Curnittte (11) . Into each well of a 96-well plate 50 μΐ of the polymorphonuclear leukocyte suspension (7.5 X 10 9 /1), 50 μΐ ferricytochrome c (2.7 g/1) and bovine serum albumm/Hanks' balanced salt solution (80 g/1) were placed. Into reference wells-50 μΐ of Superoxide dismutase (1.25 g/1) were added. Granulocytes were stimulated with phorbol myristate acetate (20 μg/l) and incubated at 37 °C for 30 minutes. Thereafter, wells were measured at 550 nm with a microplate reader (Dynatech, Denkendorf, Germany). After complete reduction of ferricytochrome c by addition of 10 μΐ Na-dithionite (half-saturated solution), the whole amount of reduced ferricytochrome c was measured again at 550 nm to obtain the relation of the ferricytochrome reduced by ΟΪ" and the total amount of fcrricytochrome. C>2 produced by polymorphonuclear leukocytes was calculated as the difference between Superoxide dismutase-containing samples and samples without superoxidc dismutase (relation of reduced to total reduced ferricytochrome c).
fercd saline with Ca 2 +/Mg 2 + plus 100 μ] luniinol (200 μηιοΐ/ΐ) or lucigcnin (1 mmol/l) were preincubated at 37 °C for 10 minutes. The stimulation was started by adding 20 μΐ of opsonizcd zymosan (1:10 diluted). The reaction was monitored at 37 °C for 50 minutes.
HOC1 assay
The HOC1 production of polymorphonuclear leukocytes (3.75 X 10'Vl) was measured by the chlorination of taurine followed by the oxidation of 5-thio-2-nilrobenzoic acid to 5,5'-dithio-bis(2-nitrobenzoic acid) (12) . Polymorphonuclear leukocytes (1 ml) were incubated in Hanks' balanced salt solution/taurine (15 mmol/1) and stimulated with 100 μΐ opsonized zymosan (stock suspension 1:10 diluted) at 37 °C for 30 minutes. After slopping the reaction by adding catalasc (290 unils), samples were centrifuged at 12000g for 10 minutes. The supernatant was mixed with freshly prepared and diluted 5-thio-2-nitrobenzoic acid solution (~~ 2 mmol/1) and immediately measured at 412 nm in a UV-spectrometer (LKJ3 Ultrospec Plus; Pharmacia, Freiburg, Germany). The amount of HOC1 produced was calculated using the molar linear absorption coefficient ε = 1410 m 2 /mol in consideration of the dilution factor (13) . Negative controls were prepared by adding Na-azide (100 μιτιοΐ/ΐ), /.-methionine (1 mmol/1) and catalase (290 units) to the same cell concentration and opsonized zymosan as stimulator.
Chemiluminescence test conditions
Chemiluminescence assays were performed on a Biolumat (LB 9505; Berthold, Wildbad, Germany). The results were evaluated with an Apple II using the ΈΙΟ' program. Samples of whole heparinized blood were first diluted 1 : 100 with phosphate buffered saline. Diluted blood (200 μΐ) samples plus 680 μΐ phosphate buf-
Statistics
The data are expressed as mean (± SD if η ^ 3). Statistical comparisons were performed with Mann-Wliitney U-tesl (a: 0.05) and using linear regression.
Results
Identification of myeloperoxidase deficient individuals using the H3 Figure 1 shows the leukograms (peroxidase activity) of five probands (proband 1-5) with different myeloperoxidase deficiencies compared to those of a normal person (control) and a proband (proband 6) with eosinophil peroxidase deficiency. Three of the five myeloperoxidase deficient probands showed extremely low mean peroxidase indices (-53 or less). Therefore, their neutrophil clusters were clearly shifted to the left. However, in only one out of these three persons 1-3 were the neutrophils and monocytes completely located in the large unstained cell area ( fig. l, proband that only the cells of this person could be totally myeloperoxidase deficient. As will be shown, this could also be confirmed by other tests. The clusters of eosinophil granulocytes of persons with myeloperoxidase deficiency did not differ from controls. For comparison, the leukogram of proband 6 with a very rare form of eosinophil peroxidase deficiency is shown in figure 1 . Due to lacking stained vesicles, the light-scattering is changed characteristically, leading to a cluster location upwards on the y-axis, and a shift to the left on the x-axis. The myeloperoxidase activity was normal (as shown by the location of the neutrophils in the leukogram). However, because of the unusual plotting of the eosinophil granulocytes, the calculation of the mean peroxidase index -22.5) is wrong.
Phagocytic behaviour of myeloperoxidase deficient granulocytes
Ninety-seven to 98% of cells of the whole myeloperoxidase deficient neutrophil population were able to phagocytose fluorescein isothiocyanate-labelled E. coli, which was not different from neutrophils with normal myeloperoxidase activity. In contrast, the phagocytic activity of every single cell in the population was remarkably higher than in normal controls (tab. 1).
Correlation between myeloperoxidase activity, myeloperoxidase content and HOCI production
In order to explore in further detail whether the H3 measurements of myeloperoxidase activity correlated to the amount of myeloperoxidase in the neutrophils, granulocytes were isolated and myeloperoxidase concentration was assayed using a myeloperoxidase enzyme immunoassay. Figure 2 shows a good linear correlation between these two quantities (r = 0.97). However, among the Measurements were carried out during a time period of 9 months. three probands with a very low mean peroxidase index (below -53), myeloperoxidase was completely absent only in one person (proband l). In accordance with this finding, only the neutrophils of this person were unable to produce HOCI (tab. 1). Although the mean peroxidase index indicated for proband 2 was comparably low, detectable amounts of myeloperoxidase (enzyme immunoassay) and low HOCI production were found in her neutrophils (tab. 1). Obviously, the mean peroxidase index cannot be calculated with exactness in this very low range. A more successful way of identifying persons with complete myeloperoxidase deficiency is the evaluation of the graphic presentation ( fig. 1 ), which clearly shows that only the neutrophils of proband l are located completely in the large unstained cell area. Tab. 2 Luminol-and lucigenin-enhanced chemiluminescence of normal and myeloperoxidase deficient cells during Stimulation of opsonized zymosan.
Data are presented as integral counts (0-60 minutes), peak and ti/2faii (time period when peak dropped to half ot its value) and expressed as mean of two experiments. 6 cells per 5 min (n = 3). However, the steadystate concentration of H 2 O 2 was rather low, not only in normal granulocytes as expected, but also in myeloperoxidase deficient granulocytes. H 2 O 2 was determined 5 minutes after addition of the stimulus zymosan by adding catalase, considering the fact that H 2 O 2 can easily penetrate cell membranes and exit the cells (14) . As can be arbitrarily calculated from one experiment shown in figure 4 and from equation (1), 161 + 80.5 =241.5 nmol oxygen were consumed by normal granulocytes during the first 5 minutes, which could, theoretically, allow a maximal production of 80. 6 cells per 5 min in myeloperoxidase deficient granulocytes. Since myeloperoxidase positive and negative granulocytes probably do not differ in their catalase and glutathione-peroxidase activities (15, 16) , it is obvious that myeloperoxidase deficient granulocytes use other compensatory H 2 O 2 consuming pathways for generating antimicrobial oxygen species (e. g. OH-radicals), instead of generating HOC1.
Chem i him i nescence
Discussion
Correlation between myeloperoxidase activity, myeloperoxidase content and HOC1 production Mean peroxidase indices below -55 are generally thought to reflect a total myeloperoxidase deficiency (17) . However, in granulocytes with very low myeloperoxidase activity, these values may not be estimated with exactness. In our opinion, much better results are achieved by considering the graphical presentation, i. e. whether the neutrophils (and monocytes) are completely in the large unstained cell area or slightly shifted to the right ( fig. 1 ). Neutrophils/monocytes of proband l, which were clearly located in the large unstained cell region, did not give a signal in the myeloperoxidase enzyme immunoassay. Generally, there was a good correlation between myeloperoxidase activity (Bayer/ Technicon H3) and the amount of myeloperoxidase in cell extracts measured by the enzyme immunoassay ( fig. 2 ).
However, it should be noted that even in the complete absence of myeloperoxidase activity, enzyme immunoassay signals could be positive since there is a crossreactivity between eosinophil peroxidase and myeloperoxidase (18) . In experiments using cell extracts of neutrophils and eosinophils previously separated by the magnetic activated cell sorter technique, using anti-CD 16 antibodies, we observed this cross-reactivity: In extracts of 10 6 neutrophils (purity: 98%), 370 ng myeloperoxidase could be detected, in 10 6 eosinophils (purity: 82%, 18% neutrophils and monocytes) an amount of eosinophil peroxidase, which corresponded to 115 ng of myeloperoxidase. Comparing 10 6 neutrophils with 10 6 eosinophils (the real amount of eosinophil peroxidase was not known), the net eosinophil peroxidase/myeioperoxidase cross-reactivity (subtraction of the 18%) would be about 10% and can therefore be neglected under normal conditions (whole blood), where the amount of neutrophils is significantly higher than the amount of eosinophils. According to the manufacturer (Biermann, Bad Nauheim, Germany), the cross-reactivity of eonsinophil peroxidase with myeloperoxidase is lower than 2%. In extracts of granulocytes of proband l we could not find any peroxidase using the enzyme immunoassay. Obviously, the amount of eosinophils was too small to detect any eosinophil peroxidase crossreactivity. Since HOC1 production was also lacking, proband l could definitively be regarded as completely myeloperoxidase deficient. The other proband with a comparably low mean peroxidase index (proband 2) was only partially myeloperoxidase deficient, which was demonstrated by the graphic presentation on Bayer/Technicon H3 ( fig. 1) , positive peroxidase values in the enzyme immunoassay (tab. 1) and production of HOC1 (tab. 1).
Phagocytosis, chemiluminescence and the respiratory burst
The chemiluminescence measurement of activated granulocytes with luminol and lucigenin gives an overall picture of the oxidative metabolism without a strong correlation to a distinct kind of reactive oxygen compound. However, it is known that luminol chemiluminescence rather reflects myeloperoxidase/H 2 O 2 /chIorite-dependent processes (19, 20) whereas lucigenin chemiluminescence is more predictive for O 2 -dependent reactions (21, 22) . The luminol dependent chemiluminescence signal was indeed drastically reduced in the proband with complete myeloperoxidase deficiency. It was also clearly diminished in proband 2 with a similar low mean peroxidase index, but still retained some myeloperoxidase activity. The other three probands with partial myeloperoxidase deficiency did not differ from controls to a greater extent, even if they clearly produced reduced amounts of HOC). This indicates the complex interplay between H2O2/HOC1 in the generation of the luminol dependent chemiluminescence signal (16, 23) .
In contrast, myeloperoxidase deficient granulocytes showed a much higher lucigenin dependent chemiluminescence than normal controls. This characteristically high increase of lucigenin dependent chemiluminescence compared to the striking decrease of luminol dependent chemiluminescence in granulocytes with myeloperoxidase deficiency versus normal controls may be used as a simple test to detect myeloperoxidase deficient probands, if an automatic blood counter of the Bayer/ Technicon H3-type (measuring myeloperoxidase activity) is not available. The enhanced Superoxide anion production (lucigenin chemiluminescence) in myeloperoxidase deficient cells was described in the literature (15, 16, 23, 24) , and may be caused by two main reasons: Hasui et al. (25) and Stendahl et al.· (26) reported an enhanced phagocytosis of myeloperoxidase deficient granulocytes. This report stands in contrast to earlier observations of Cramer et al. (27) and Larrocha et al. (28) , who demonstrated a normal phagocytic behaviour of the myeloperoxidase deficient granulocytes. We could confirm the results that myeloperoxidase deficient granulocytes are able to phagocytose more particles than normal ones (tab. 1). The elevated lucigenin dependent chemiluminescence observed in all the five myeloperoxidase deficient patients investigated is probably associated with this enhanced phagocytosis.
The enhanced phagocytosis could be due to increased receptor expression (complement 3b-, Fc-receptor) on the surface of myeloperoxidase deficient granulocytes, which may contribute to the complex pattern of luminol and lucigenin chemiluminescence (29, 30) . In myeloperoxidase deficient cells, additional numbers of these receptors may be more easily translocated from an intracellular pool to the cell membrane during stimulation (31) . This is in agreement with Stendahl et al. (26) , who showed that the addition of extracellular myeloperoxidase in zymosan-activated adherent myeloperoxidase deficient granulocytes decreased the complement 3b-and Fc-mediated phagocytosis.
Furthermore, the longer duration of the lucigenin chemiluminescence signal in myeloperoxidase deficient granulocytes compared to normal cells (i.e. the prolongated fall of chemiluminescence signals after the peak-maximum, indicated as t. /2fa n, tab. 2) may also reflect the fact that inhibition of NADPH-oxidase is retarded. This is probably due to the absence or low levels of HOC1, which contributes to the termination of the respiratory burst in myeloperoxidase-positive granulocytes (4).
The enhanced production of reactive oxygen compounds as a result of these effects (enhanced phagocytosis due to increased complement 3b, Fc-receptor expression and reduced inhibition of NADPH-oxidase because of the lack of HOC1 production) may, at least partly, compensate for myeloperoxidase deficiency. The exact species are presently not known (32) . Possible candidates in granulocytes and monocytes could be OH- (33) . The experiments for the identification of these alradicals, NO/ONOO formation, as well as substances ternative H 2 O 2 -pathways in myeloperoxidase deficient such as neopterin, which was previously described as an cells are in progress, enhancer of cytotoxic effects of H 2 O 2 against E. call
